ADARx Pharmaceuticals (ADRX) vs Tyra Biosciences (TYRA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
ADARx Pharmaceuticals is the larger company by market cap ($1.42 billion vs $1.39 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADRX | TYRA |
|---|---|---|
| Share price | $12.79 | $20.12 |
| Market cap | $1.42B | $1.39B |
| 1-day change | -9.68% | +1.98% |
| YTD return | — | -23.47% |
| 1-year return | — | -4.73% |
| 5-year return | — | -15.71% |
| EPS (TTM) | $-6.75 | $-2.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | — | $-119.95M |
| 52-week high | $23.21 | $40.65 |
| 52-week low | $12.50 | $18.25 |
| Distance from 52-week high | -44.89% | -50.50% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +167.79% | +135.83% |
| Average volume | 650.63K | 852.56K |
| Shares outstanding | 111.19M | 69.08M |
| Employees | 100 | 87 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ADARx Pharmaceuticals
ADRX stock →ADARx Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing siRNA therapeutics to treat a broad spectrum of diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees
About Tyra Biosciences
TYRA stock →Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
ADRX vs TYRA FAQ
Which is bigger, ADARx Pharmaceuticals or Tyra Biosciences?
ADARx Pharmaceuticals (ADRX) is larger, with a market capitalization of $1.42B compared with $1.39B for Tyra Biosciences (TYRA).
Are ADARx Pharmaceuticals and Tyra Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.